Skip to content

Antimicrobials Stewardship by Pharmacist

Appropriate Use of Controlled Broad-spectrum Antimicrobials by Establish Stewardship and Execute by Antibiotic Pharmacist

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02768454
Enrollment
200
Registered
2016-05-11
Start date
2015-09-30
Completion date
2016-09-30
Last updated
2016-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

broad-spectrum antimicrobial, antibiotics pharmacist

Brief summary

To study the outcome of antibiotics stewardship

Detailed description

Retrospective cohort study by medical review and evaluation of broad-spectrum antibiotics to determine how appropriately it was bing used.

Interventions

DRUGmedical review of controlled broad-spectrum antibiotics

medical review of outcome of antibiotics stewardship by pharmacists and infectious disease physicians

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Inpatient with infectious disease and under broad-spectrum antibiotics

Exclusion criteria

* Poor prognosis was diagnosed or received conservative therapy only.

Design outcomes

Primary

MeasureTime frameDescription
The percentage of appropriateness of empirical antibiotics choosing.up to 8 weeksFor example,the inappropriate of piperacillin-tazobactam as empirical therapy was numbers of participants with no risk factors of deep tissue infection or DM foot /Number of participants treated with piperacillin-tazobactam for soft tissue infection.
The percentage of appropriateness of de-escalation of therapy.up to 8 weeksFor example,continued piperacillin-tazobactam was seen to be inappropriate when microbiologic results and clinical status permit de-escalation.

Secondary

MeasureTime frame
Number of adverse events of antibiotics were recorded.up to 8 weeks

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026